ArticleCancers2024

Bufalin Suppresses Head and Neck Cancer Development by Modulating Immune Responses and Targeting the β-Catenin Signaling Pathway.

Nour Mhaidly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.